Vanderbilt University Medical Center: Cardiac Antigen Identified As Mechanism For Heart Complication With Immunotherapy-Related Myocarditis
November 17, 2022
November 17, 2022
NASHVILLE, Tennessee, Nov. 17 (TNSjou) -- Vanderbilt University Medical Center issued the following news:
Myocarditis is a complication that can occur in cancer patients treated with immune checkpoint inhibitors. Although the adverse event is rare -- affecting less than 1% of patients given the immunotherapy -- the mortality rate is nearly 50%. Now, researchers from Vanderbilt-Ingram Cancer Center have identified the mechanism for the deadly heart inflammation.
The rese . . .
Myocarditis is a complication that can occur in cancer patients treated with immune checkpoint inhibitors. Although the adverse event is rare -- affecting less than 1% of patients given the immunotherapy -- the mortality rate is nearly 50%. Now, researchers from Vanderbilt-Ingram Cancer Center have identified the mechanism for the deadly heart inflammation.
The rese . . .